Renalytix plc Form 6-K Current Report Filed 2023-02-08

Por um escritor misterioso

Descrição

Renalytix plc Form 6-K Current Report Filed 2023-02-08
Relay Therapeutics, Inc. Form 8-K Current Report Filed 2023-04-18
Renalytix plc Form 6-K Current Report Filed 2023-02-08
Renalytix
Renalytix plc Form 6-K Current Report Filed 2023-02-08
Millennium Management Llc Portfolio Holdings
Renalytix plc Form 6-K Current Report Filed 2023-02-08
Renalytix plc: Renalytix Reports Financial Results for First Quarter of Fiscal Year 2024
Renalytix plc Form 6-K Current Report Filed 2023-02-08
EDGAR Filing Documents for 0000950170-23-013199
Renalytix plc Form 6-K Current Report Filed 2023-02-08
Relay Therapeutics, Inc. Form 8-K Current Report Filed 2023-04-18
Renalytix plc Form 6-K Current Report Filed 2023-02-08
Stock Market News 2023-05-25
Renalytix plc Form 6-K Current Report Filed 2023-02-08
Relay Therapeutics, Inc. Form 8-K Current Report Filed 2023-04-18
Renalytix plc Form 6-K Current Report Filed 2023-02-08
Relay Therapeutics, Inc. Form 8-K Current Report Filed 2023-04-18
Renalytix plc Form 6-K Current Report Filed 2023-02-08
Medtronic reports second quarter fiscal 2024 financial results
Renalytix plc Form 6-K Current Report Filed 2023-02-08
Rentokil Initial plc Reports Revenue Results for the Third Quarter of 2023 -October 19, 2023 at 02:00 am EDT
de por adulto (o preço varia de acordo com o tamanho do grupo)